...
首页> 外文期刊>South Asian Journal of Cancer >Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
【24h】

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies

机译:血液和非血液系统恶性肿瘤患者真菌血流感染致死的预后因素

获取原文
           

摘要

Background:This single center retrospective analysis was undertaken to identify the incidence, clinical impact, and prognostic factors for mortality associated with fungal blood stream infections (BSI) in cancer patients.Materials and Methods:One hundred and twenty four patients had 169 episodes of fungal BSI. Incidence has not changed over a 10 year period but non albicans candida species are the predominant fungal isolates. Mortality with fungal BSI was significantly higher than that with other microbial agents. Risk of mortality was associated with renal dysfunction and Candida albicans as the isolate. Type of chemotherapy, patient characteristics, and neutrophil count did not influence the mortality following fungal BSI.Conclusion:Fungal BSI is rare and the incidence has not changed in this hospital. Mortality associated with fungal BSI is high. Risk score at the time of developing fungal BSI has prognostic potential to identify patients with higher risk of mortality associated with fungal BSI.
机译:背景:这项单中心回顾性分析旨在确定癌症患者与真菌血流感染(BSI)相关的死亡率的发生率,临床影响和预后因素。材料与方法:124位患者发生了169次真菌病BSI。十年来发病率没有变化,但非白色念珠菌是主要的真菌分离株。真菌BSI的死亡率显着高于其他微生物制剂。死亡风险与肾功能不全和白色念珠菌分离有关。化疗的类型,患者的特征和中性粒细胞计数均不影响真菌性BSI的死亡率。结论:真菌性BSI很少见,在该医院的发病率没有改变。与真菌BSI相关的死亡率很高。发生真菌性BSI时的风险评分具有确定与真菌性BSI相关的较高死亡风险的患者的预后潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号